The Chan Zuckerberg Initiative announced March 2 the launch of a new biomedical research hub in Chicago that will bring together the University of Chicago, Northwestern University and the University of Illinois Urbana-Champaign, with the goal of solving grand challenges in science on a 10- to 15-year time horizon.
The Chan Zuckerberg Biohub Chicago will build upon the successes of the first Chan Zuckerberg Biohub in San Francisco, and it is the first to expand the CZ Biohub Network out of California. The CZ Biohub Network is a groundbreaking collaborative model for scientific research with leading research institutions in different regions.
Members of the CZ Biohub Network will partner to advance science and develop technologies that help understand how cells and tissues function, and that increase our understanding of human health and disease.
“We are excited to scale this successful model of collaborative science into a larger network by welcoming the new Chan Zuckerberg Biohub in Chicago,” said CZI co-founder and co-CEO Priscilla Chan. “This institute will embark on science to embed miniaturized sensors into tissues that will allow us to understand how healthy and diseased tissues function in unprecedented detail. This might feel like science fiction today, but we think it’s realistic to achieve huge progress in the next 10 years. I look forward to the advances in science and technology that this new Biohub will spur in studying how tissues function to understand what goes wrong in disease and how to fix it.”
Click here to read the full story.
This story was first published by UChicago News.
